Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
From the U.S. FDA-approved label for Mirtazapine. Full label: DailyMed.
Mirtazapine tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
From the U.S. FDA-approved label for Mirtazapine. Full label: DailyMed.
Starting dose: 15 mg once daily; may increase up to maximum recommended dose of 45 mg once daily., Administer orally once daily, preferably in the evening prior to sleep., Reduce dose gradually when discontinuing mirtazapine tablets. 2.1 Recommended Dosage The recommended starting dose of mirtazapine tablets is 15 mg once daily, administered orally, preferably in the evening prior to sleep. If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a maximum of 45 mg per day.
Directions from the U.S. FDA-approved label for Mirtazapine — your doctor or pharmacist may advise differently.
Mirtazapine tablets are contraindicated in patients: Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome., With a known hypersensitivity to mirtazapine or to any of the excipients in mirtazapine tablets.
Excerpt from the U.S. FDA-approved label for Mirtazapine. Talk to a pharmacist or doctor before use.
Agranulocytosis: If sore throat, fever, stomatitis or signs of infection occur, along with a low white blood cell count, treatment with mirtazapine should be discontinued and the patient should be closely monitored., Serotonin Syndrome: Increased risk when co-administered with other serotonergic drugs (e.g., SSRI, SNRI, triptans), but also when taken alone.
Warnings and precautions excerpt from the U.S. FDA-approved label for Mirtazapine — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are described in more detail in other sections of the prescribing information: Hypersensitivity, Suicidal Thoughts and Behaviors, Agranulocytosis, Serotonin Syndrome, Angle-Closure Glaucoma, QT Prolongation and Torsades de Pointes, Increased Appetite and Weight Gain, Somnolence, Activation of Mania or Hypomania, Seizures, Elevated Cholesterol and Triglycerides, Hyponatremia, Transaminase…
Excerpt from the U.S. FDA-approved label for Mirtazapine — not a complete list. Talk to a pharmacist or doctor about side effects.
13 brands · 5 makers in the NepalDoc catalog — see the full Mirtazapine guide →
Storage Store at 25°C (77°F); Protect from light and moisture.
Storage information from the U.S. FDA-approved label for Mirtazapine.
What is Mirtaz 15?
Mirtaz 15mg Tablet is a Mirtazapine medicine made by Sun Pharmaceutical Industries Ltd. It comes as 15mg Tablet.
What is Mirtaz 15 used for?
According to its FDA label, Mirtazapine is used for the treatment of major depressive disorder (MDD) in adults.
What is the generic name of Mirtaz 15?
The generic name of Mirtaz 15 is Mirtazapine.
Which brands of Mirtazapine are available in Nepal?
13 brands of Mirtazapine are listed in the NepalDoc catalog, from 5 makers — including Miraz 15mg Tablet, Miraz 7.5mg Tablet, Mirdep 15mg Tablet, Mirdep 7.5mg Tablet, Mirnite 15mg Tablet, Mirnite 30mg Tablet.
What are the side effects of Mirtazapine?
The following adverse reactions are described in more detail in other sections of the prescribing information: Hypersensitivity, Suicidal Thoughts and Behaviors, Agranulocytosis, Serotonin Syndrome, Angle-Closure Glaucoma, QT Prolongation and Torsades de Pointes, Increased Appetite and Weight Gain, Somnolence, Activation of Mania or Hypomania, Seizures, Elevated Cholesterol and Triglycerides, Hyponatremia, Transaminase…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.